Literature DB >> 20348359

Obesity treatment tailored for a Catholic faith community: a feasibility study.

Rebecca A Krukowski1, Natalie K Lueders, T Elaine Prewitt, D Keith Williams, Delia Smith West.   

Abstract

Most faith-based obesity intervention research has been conducted in African-American Protestant churches. However, Catholic communities might also benefit from a faith-tailored approach. Overweight Catholic individuals (n = 34, 71% female) were randomized to a Catholic-tailored or standard behavioral 16-week group weight control program. Both conditions experienced significant weight losses (Catholic-tailored: -8.1 + 4.1%, Standard: -7.9 + 4.2%); however, treatment satisfaction was significantly greater in the Catholic-tailored program. The Catholic-tailored program experienced trends for greater attendance, more completed self-monitoring journals, and smaller weight regain six months post-treatment than the standard program. Catholic-tailored programs may represent a feasible, culturally acceptable and effective approach to weight loss/maintenance in this faith community.

Entities:  

Mesh:

Year:  2010        PMID: 20348359     DOI: 10.1177/1359105309353645

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  4 in total

1.  Divine Interventions: Faith-Based Approaches to Health Promotion Programs for Latinos.

Authors:  Andiara Schwingel; Patricia Gálvez
Journal:  J Relig Health       Date:  2016-12

2.  A qualitative study of faith leaders' perceptions of health and wellness.

Authors:  Benjamin Webb; Melissa Bopp; Elizabeth A Fallon
Journal:  J Relig Health       Date:  2013-03

3.  Filling the Gaps: The Role of Faith-Based Organizations in Addressing the Health Needs of Today's Latino Communities.

Authors:  Brook E Harmon; Michael Schmidt; Fatima Escobar; Emily Rose N San Diego; April Steele
Journal:  J Relig Health       Date:  2021-04

Review 4.  Complementary religious and spiritual interventions in physical health and quality of life: A systematic review of randomized controlled clinical trials.

Authors:  Juliane Piasseschi de Bernardin Gonçalves; Giancarlo Lucchetti; Paulo Rossi Menezes; Homero Vallada
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.